Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.

Over a grill, Roni-Kay Elser and her husband, Jim, admire a fresh rack of ribs. “So you want to take one good bite of a rib. You want to have that one bite through,” said Elser, after biting into the ...

Findings from a study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer ...

In September, the Trump administration took what it called “bold actions” on autism that included touting the generic drug leucovorin as a promising treatment. In a news release, Marty Makary, ...

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.

To share your story, or find out how to get involved with CNBC Cures, email CNBC.cures@cnbc.com The first annual CNBC Cures Summit, was a landmark live event bringing together the most influential ...

Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival. A new comprehensive review analyzes decades of global clinical data on boron neutron capture ...

Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...

Findings from a study led by researchers at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) support the ...

High-grade serous ovarian cancer is the most common and aggressive form of ovarian cancer and often becomes resistant to ...